# oxcarbazepine

NDC: 33342-259
Generic name: oxcarbazepine
Labeler / Manufacturer: Macleods Pharmaceuticals Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: FOR SUSPENSION
Routes: ORAL
Marketing started: 20250711

FDA application: ANDA207300

## Active ingredients

- OXCARBAZEPINE: 300 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"33342-259"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=33342-259
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=962098cc-2d84-4723-a296-b110f1fd659e
